Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Phase I/II Study of Lenalidomide Combined with DA-EPOCH and Rituximab (DA-EPOCH-R 2 ) in Primary Effusion Lymphoma in Patients with or without HIV

Kathryn Lurain, MDMPH, Ramya Ramaswami, MBBS,MPH, Anaida Widell, RN, Irene Ekwede, RN, Jomy George, PharmD, Maryalice Stetler-Stevenson, MD PhD, Mark Raffeld, MD, Constance M. Yuan, MD PhD, Joseph Ziegelbauer, PhD, Frank Maldarelli, MD PhD, William D. Figg, PharmD, Cody Peer, PhD, Seth M. Steinberg, PhD, Denise Whitby, Thomas S. Uldrick, MD MS, Robert Yarchoan, MD

Blood (2019) 134 (Supplement_1): 4096.

https://doi.org/10.1182/blood-2019-122070

Published: 2019

Journal Articles

Economic Burden of Adverse Events Among Patients with Chronic Myelogenous Leukemia Treated with BCR-ABL1 Tyrosine Kinase Inhibitors

Jay Lin, PhD MBA, Makenbaeva Dinara, MD MBA, Bilmes Robyn, PharmD, BCOP, Melissa Lingohr-Smith, PhD, Nicola Wallis, MRCPath, FFPM

Blood (2015) 126 (23): 876.

https://doi.org/10.1182/blood.V126.23.876.876

Published: 2015

Journal Articles

Incidence, Etiology and Outcome of Pleural Effusions in Patients Undergoing Allogeneic Stem Cell Transplantation

Dipenkumar Modi, MD, Abhinav Deol, MD, Divaya Bhutani, MD, Lawrence G. Lum, MD DSC, Lois Ayash, MD, Voravit Ratanatharathorn, MD, Hyejeong Jang, MS, Seongho Kim, PhD, Richard Manasa, B.S., Kendra Mellert, M.S.A.; C.C.R.P., Joseph P. Uberti, MD, PhD

Blood (2015) 126 (23): 5442.

https://doi.org/10.1182/blood.V126.23.5442.5442

Published: 2015

Journal Articles

Clinical Relevance of CD45+/CD19- Stem-like Tumor Cells in Patients with Mantle Cell Lymphoma: A Single Center Experience

Sung Min Kim, Seung-Tae Lee, MD, Kyung Ju Ryu, Hee-Jin Kim, Sun-Hee Kim, Kwai Han Yoo, Young Hyeh Ko, MD PhD, Won Seog Kim, MD PhD, Seok Jin Kim, MD PhD

Blood (2014) 124 (21): 1622.

https://doi.org/10.1182/blood.V124.21.1622.1622

Published: 2014

Journal Articles

Anti-CD19 Chimeric Antigen Receptor (CAR) T Cells Produce Complete Responses With Acceptable Toxicity But Without Chronic B-Cell Aplasia In Children With Relapsed Or Refractory Acute Lymphoblastic Leukemia (ALL) Even After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Daniel W. Lee, III, MD, Nirali N Shah, MD, Maryalice Stetler-Stevenson, MD, PhD, Marianna Sabatino, Cindy Delbrook, RN, Kelly Richards, RN, James N Kochenderfer, M.D., Steven A. Rosenberg, M.D., Ph.D., David Stroncek, MD, Alan S. Wayne, MD, Crystal L Mackall, MD

Blood (2013) 122 (21): 68.

https://doi.org/10.1182/blood.V122.21.68.68

Published: 2013

Journal Articles

Malignant Pleural Effusion and Advanced Stage Low-Grade Non-Hodgkin's Lymphoma Successfully Treated with Intrapleural Instillation of Rituximab

Anwarul Islam, MD, Hiroshi Takita, M.D.

Blood (2012) 120 (21): 4891.

https://doi.org/10.1182/blood.V120.21.4891.4891

Published: 2012

Journal Articles

Preclinical Activity of Brentuximab Vedotin (SGN-35) in Primary Effusion Lymphoma (PEL),

Shruti Bhatt, Brittany Ashlock, Yaso Natkunam, MD, PhD, Juan Carlos Ramos, MD, Enrique Mesri, PhD, Izidore S Lossos, MD

Blood (2011) 118 (21): 3728.

https://doi.org/10.1182/blood.V118.21.3728.3728

Published: 2011

Journal Articles

Clonally Related B-NHL Populations and Cell Lines Harbor Subsets with Significant Phenotypic and Functional Heterogeneity.

Sherry A. Wuensch, Randall M. Rossi, Richard Burack, Paul G. Rothberg, Craig T. Jordan, Faith M Young

Blood (2009) 114 (22): 1699.

https://doi.org/10.1182/blood.V114.22.1699.1699

Published: 2009

Journal Articles

Distinct Transforming and Leukemogenic Activities of Tel-Arg and Tel-Abl Oncogenes in Mice: Possible Negative Role for the Transforming Activity in C-Terminus of Arg

Keiko Okuda, MD, PhD, Nari Harakawa, MD, PhD, Richard A VanEtten, MD, PhD, Nihal Patel, Naochika Domae, MD, PhD, Yuko Sato, MD, PhD, Hideyo Hirai, MD, PhD

Blood (2008) 112 (11): 2845.

https://doi.org/10.1182/blood.V112.11.2845.2845

Published: 2008

Journal Articles

The Novel Human Ph + Acute Lymphoblastic Leukemia Cell Line PhALL3.1 Is Amenable to Retroviral Gene Transfer and Mimics Human Disease Progression in SCID-Beige Mice

Mark G. Frattini, MD, PhD, Elmer Santos, MD, PhD, Mark Lawrence Heaney, MD, PhD, Peter Maslak, MD, Suresh C Jhanwar, PhD, Steven M Larson, MD, Elisa De Stanchina, PhD, Bayard Clarkson, MD, Renier J. Brentjens, MD, PhD

Blood (2008) 112 (11): 4875.

https://doi.org/10.1182/blood.V112.11.4875.4875

Published: 2008

Journal Articles

A Review of the Economic Burden of Pleural and Pericardial Effusions in Cancer Patients.

Sarah Y. Liou, Jennifer M. Stephens, PharmD, Kimbach T. Tran, MPH, MS, Marc F. Botteman, MSc, MA

Blood (2006) 108 (11): 5514.

https://doi.org/10.1182/blood.V108.11.5514.5514

Published: 2006

Journal Articles

Proteinase-Activated Receptor 1, 3 Expression in Primary Human Carcinoma Cells.

Wan-Zhuo Xie, He Huang, Zhen Cai, Mao-Fang Lin, Frank Gieseler

Blood (2005) 106 (11): 4113.

https://doi.org/10.1182/blood.V106.11.4113.4113

Published: 2005

Journal Articles

Loss of Heterozygosity on Chromosome 6q14-q24 Confers Poor Outcome on Children and Adolescents with T-Cell Lymphoblastic Lymphoma.

Birgit Burkhardt, MD, Jochen Bruch, PhD, Franziska Mueller, Janina Salzburg, MD, Jochen Harbott, PhD, Alfred Reiter, MD

Blood (2005) 106 (11): 2809.

https://doi.org/10.1182/blood.V106.11.2809.2809

Published: 2005

Journal Articles

Establishment and characterization of a human plasma cell myeloma culture having a rearranged cellular myc proto-oncogene

AF Gazdar, HK Oie, IR Kirsch, GF Hollis

Blood (1986) 67 (6): 1542–1549.

https://doi.org/10.1182/blood.V67.6.1542.1542

Published: 1986

NARROW

Phase I/II Study of Lenalidomide Combined with DA-EPOCH and Rituximab (DA-EPOCH-R 2 ) in Primary Effusion Lymphoma in Patients with or without HIV

Economic Burden of Adverse Events Among Patients with Chronic Myelogenous Leukemia Treated with BCR-ABL1 Tyrosine Kinase Inhibitors

Incidence, Etiology and Outcome of Pleural Effusions in Patients Undergoing Allogeneic Stem Cell Transplantation

Clinical Relevance of CD45+/CD19- Stem-like Tumor Cells in Patients with Mantle Cell Lymphoma: A Single Center Experience

Anti-CD19 Chimeric Antigen Receptor (CAR) T Cells Produce Complete Responses With Acceptable Toxicity But Without Chronic B-Cell Aplasia In Children With Relapsed Or Refractory Acute Lymphoblastic Leukemia (ALL) Even After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Malignant Pleural Effusion and Advanced Stage Low-Grade Non-Hodgkin's Lymphoma Successfully Treated with Intrapleural Instillation of Rituximab

Preclinical Activity of Brentuximab Vedotin (SGN-35) in Primary Effusion Lymphoma (PEL),

Clonally Related B-NHL Populations and Cell Lines Harbor Subsets with Significant Phenotypic and Functional Heterogeneity.

Distinct Transforming and Leukemogenic Activities of Tel-Arg and Tel-Abl Oncogenes in Mice: Possible Negative Role for the Transforming Activity in C-Terminus of Arg

The Novel Human Ph + Acute Lymphoblastic Leukemia Cell Line PhALL3.1 Is Amenable to Retroviral Gene Transfer and Mimics Human Disease Progression in SCID-Beige Mice

A Review of the Economic Burden of Pleural and Pericardial Effusions in Cancer Patients.

Proteinase-Activated Receptor 1, 3 Expression in Primary Human Carcinoma Cells.

Loss of Heterozygosity on Chromosome 6q14-q24 Confers Poor Outcome on Children and Adolescents with T-Cell Lymphoblastic Lymphoma.

Establishment and characterization of a human plasma cell myeloma culture having a rearranged cellular myc proto-oncogene

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only